Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multicenter evaluation of light transmission platelet aggregation reagents: communication from the ISTH SSC Subcommittee on Platelet Physiology.
Alessi MC, Coxon C, Ibrahim-Kosta M, Bacci M, Voisin S, Rivera J, Greinacher A, Raster J, Pulcinelli F, Devreese KMJ, Mullier F, McCormick AN, Frontroth JP, Pouplard C, Sachs UJ, Diaz I, Bermejo N, Camera M, Fontana P, Bauters A, Stepanian A, Cozzi MR, Sveshnikova AN, Faille D, Hollon W, Chitlur M, Casonato A, Lasne D, Lavenu-Bombled C, Fiore M, Hamidou B, Hurtaud-Roux MF, Saultier P, Goumidi L, Gresele P, Lordkipanidzé M. Alessi MC, et al. Among authors: sachs uj. J Thromb Haemost. 2023 Sep;21(9):2596-2610. doi: 10.1016/j.jtha.2023.05.027. Epub 2023 Jun 16. J Thromb Haemost. 2023. PMID: 37331519 Free article.
Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany-Results from the SeBluCo Study 2020-2022.
Offergeld R, Preußel K, Zeiler T, Aurich K, Baumann-Baretti BI, Ciesek S, Corman VM, Dienst V, Drosten C, Görg S, Greinacher A, Grossegesse M, Haller S, Heuft HG, Hofmann N, Horn PA, Houareau C, Gülec I, Jiménez Klingberg CL, Juhl D, Lindemann M, Martin S, Neuhauser HK, Nitsche A, Ohme J, Peine S, Sachs UJ, Schaade L, Schäfer R, Scheiblauer H, Schlaud M, Schmidt M, Umhau M, Vollmer T, Wagner FF, Wieler LH, Wilking H, Ziemann M, Zimmermann M, der Heiden MA. Offergeld R, et al. Among authors: sachs uj. Pathogens. 2023 Apr 2;12(4):551. doi: 10.3390/pathogens12040551. Pathogens. 2023. PMID: 37111436 Free PMC article.
Efficacy of emicizumab in patients with severe haemophilia A without factor VIII inhibitors in Germany: evaluation of real-life data documented by the smart medication eDiary.
Escuriola Ettingshausen C, Eberl W, Eichler H, Fischer R, Hart C, Holstein K, Knöfler R, Kreutz J, Kühnöl CD, Miesbach WA, Pfrepper C, Rösch A, Sachs UJ, Trautmann-Grill K, Mondorf W. Escuriola Ettingshausen C, et al. Among authors: sachs uj. Ther Adv Hematol. 2024 Nov 29;15:20406207241295653. doi: 10.1177/20406207241295653. eCollection 2024. Ther Adv Hematol. 2024. PMID: 39618509 Free PMC article.
Monitoring and management of hemolytic disease of the fetus and newborn based on an international expert Delphi consensus.
Mustafa HJ, Sambatur EV, Shamshirsaz AA, Johnson S, Moise KJ Jr, Baschat AA, Joanne Verweij EJT, Javinani A, Kilby MD, Lopriore E, Rose R, Devlieger R, Snowise S, Sachs UJ, Khalil A; HDFN Delphi Working Group. Mustafa HJ, et al. Among authors: sachs uj. Am J Obstet Gynecol. 2025 Mar;232(3):280-300. doi: 10.1016/j.ajog.2024.11.003. Epub 2024 Nov 14. Am J Obstet Gynecol. 2025. PMID: 39547350
Comorbidity and adverse events in acquired hemophilia A: data from the GTH-AHA-EMI study.
Burgmann CH, Sachs UJ, Trautmann-Grill K, Pfrepper C, Knöbl P, Greil R, Oldenburg J, Miesbach W, Holstein K, Eichler H, Möhnle P, Höpting M, Dobbelstein C, Klamroth R, Tiede A. Burgmann CH, et al. Among authors: sachs uj. Res Pract Thromb Haemost. 2024 Sep 5;8(7):102565. doi: 10.1016/j.rpth.2024.102565. eCollection 2024 Oct. Res Pract Thromb Haemost. 2024. PMID: 39420971 Free PMC article.
Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn.
Moise KJ Jr, Ling LE, Oepkes D, Tiblad E, Verweij EJTJ, Lopriore E, Smoleniec J, Sachs UJ, Bein G, Kilby MD, Miller RS, Devlieger R, Audibert F, Emery SP, Markham K, Norton ME, Ocón-Hernández O, Pandya P, Pereira L, Silver RM, Windrim R, Streisand JB, Leu JH, Mirza A, Smith V, Schwartz LB, Tjoa ML, Saeed-Khawaja S, Komatsu Y, Bussel JB; UNITY Study Group. Moise KJ Jr, et al. Among authors: sachs uj. N Engl J Med. 2024 Aug 8;391(6):526-537. doi: 10.1056/NEJMoa2314466. N Engl J Med. 2024. PMID: 39115062 Clinical Trial.
Emicizumab versus immunosuppressive therapy for the management of acquired hemophilia A.
Hart C, Klamroth R, Sachs UJ, Greil R, Knoebl P, Oldenburg J, Miesbach W, Pfrepper C, Trautmann-Grill K, Pekrul I, Holstein K, Eichler H, Weigt C, Schipp D, Werwitzke S, Tiede A. Hart C, et al. Among authors: sachs uj. J Thromb Haemost. 2024 Oct;22(10):2692-2701. doi: 10.1016/j.jtha.2024.06.010. Epub 2024 Jun 25. J Thromb Haemost. 2024. PMID: 38936699 Free article.
148 results